GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

GETI.B

184.25

+1.04%↑

EKTA.B

56.5

+1.25%↑

AMBEA

127.8

-2.29%↓

ARJOB

24.92

-0.24%↓

MSON.B

11.85

+3.49%↑

Home・Elenco Azioni・Attendo AB

Attendo AB

Chiusa

98.8 -0.4

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

97.4

Massimo

99.5

Metriche Chiave
By Trading Economics
Entrata	161M 494M
Vendite	27M 4.8B
P/E Media del settore	18.672 57.833
EPS	1.65
Rendimento da dividendi	1.8
Margine di Profitto	10.3
Dipendenti	33,000
EBITDA	-79M 1.1B

Dividendi
By Dow Jones
Rendimento da dividendi Media del settore	1.80% 2.47%

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	11M 15B
Apertura precedente	99.2
Chiusura precedente	98.8

Attendo AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 mar 2026, 23:47 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Discorsi di Mercato

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Discorsi di Mercato

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Discorsi di Mercato

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Discorsi di Mercato

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Discorsi di Mercato

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Discorsi di Mercato

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Utili

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Utili

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Utili

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Principali Notizie su Eventi

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Discorsi di Mercato

Utili

Principali Notizie su Eventi

Basic Materials Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Attendo AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Attendo AB

Attendo AB (publ) provides health and care services in Scandinavia and Finland. The company offers nursing homes for people with dementia or physical care requirements; home care services, including care, meals, cleaning, laundry, evening and night, and home health care services for older people; homes for people of various ages with a range of disabilities or care needs; respite and companion services, as well as short term accommodation; homes and other care services for people with neuropsychiatric and psychosocial impairments; and social-worker supported foster care, crisis and emergency accommodation, HVB-homes, addiction care, and various forms of supportive housing services. Attendo AB (publ) was founded in 1985 and is headquartered in Danderyd, Sweden.